Intra-rater Reliability and Agreement Between Two Dual Task Tests; WBB and Gait Test.

Intra-rater Reliability and Agreement Between Static Balance Test Using Nintendo Wii Balance Board and Gait Test Under Dual Task Conditions in Community-dwelling Older Adults.

Agreement and intra-rater reliability between static balance test using Nintendo Wii Balance Board and gait test under dual-task conditions in community-dwelling older adults.

Study Overview

• Status: Recruiting
• Conditions: Balance; Distorted
• Intervention / Treatment: Behavioral: Dual task balance test

Detailed Description

Participants:

Investigators aim to recruit a minimum of 30 participants aged 65 years or above through convenience sampling at an senior activity centre in the Municipality of Aalborg. Participants inclusion critiria is age about 65, the ability to stand for 30 seconds unaided and the ability to walk 8 meters. Exclusion critiria is severe cognitive impairment (e.g., dementia).

Procedure:

Each participant will undergo two testdays separated by approximately two weeks. Both testdays have the same number and order of tests and are placed approximately the same time of the day. At the first testday descriptive information for each participant is collected.

Measuring device:

The Nintendo Wii Balance Board (Nintendo, Kyoto, Japan) is a small portable force plate measuring sway ellipse area and sway speed.

Analysis:

Will include intra-rater reliability for each test and agreement between the two. Calculations of balance/gait costs will be made to unify the unit and to compare the two tests to each other. Results shown by intraclass correlation coeffients and Bland Altman plots.

• Study Type: Observational
• Enrollment (Anticipated): 30

Contacts and Locations

• Study Contact: Name: Eriksen, student; Phone Number: 004522234454; Email: martin.eriksen@rn.dk
• Study Contact Backup: Name: Gade, MD; Phone Number: 004552505753; Email: gustav.soerensen@rn.dk

Study Locations

• Denmark
  • Aalborg
    • Vodskov, Aalborg, Denmark, 9310
      • Recruiting
      • Liselund Aktivitets Center
      • Contact: Elstrøm; Phone Number: 004599313298; Email: qr-aeh@aalborg.dk

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 65 years and older (Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Minimum 65 year-old community dwelling citizens at activity centers.

Description

Inclusion Criteria:

• Minimum 65 years old.
• Community dwelling

Exclusion Criteria:

• Unable to stand unsupported for 30 seconds
• Unable to walk 8 meters unsupported

Study Plan

How is the study designed?

Design Details

• Observational Models: Other
• Time Perspectives: Cross-Sectional

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Intra-rater reliability for the gait test and the WBB test.	Comparing the dual task costs for each test between test and retest. Assessments through intraclass correlation coefficient and reportings in accordance with Guidelines for Reporting Reliability and Agreement Studies (GRRAS).	Through study completion, app. 8 months.

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Agreement between the gait test and the WBB test as dual task measurements.	Comparing the dual task costs between the gait test and the Wii Balance Board test. Data assessment through Bland Altman plots and reportings in accordance with Guidelines for Reporting Reliability and Agreement Studies (GRRAS).	Through study completion, app. 8 months.
Descriptive data.	Qustionnairies consisting of Tilburg Frailty Indicator, Vulnerable Elders Survey 13, Short Falls Efficacy Scale, previous falls, medications and Orientations-Memory-Concentrations test. Data assessment through histograms and Shapiro Wilk tests and reported by means and standard deviations, medians and interquartile ranges, and numbers and percentages.	Through study completion, app. 8 months.

Collaborators and Investigators

• Sponsor: Aalborg University Hospital
• Investigators: Principal Investigator: Martin Eriksen, Aalborg University Hospital

Study record dates

Study Major Dates

• Study Start (Actual): October 27, 2020
• Primary Completion (Anticipated): January 6, 2021
• Study Completion (Anticipated): January 6, 2021

Study Registration Dates

• First Submitted: January 4, 2021
• First Submitted That Met QC Criteria: January 5, 2021
• First Posted (Actual): January 8, 2021

Study Record Updates

• Last Update Posted (Actual): January 8, 2021
• Last Update Submitted That Met QC Criteria: January 5, 2021
• Last Verified: January 1, 2021

More Information

Terms related to this study

• Other Study ID Numbers: 2020-096

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: Undecided

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No